Filing Details

Accession Number:
0001209191-21-021428
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-17 17:10:05
Reporting Period:
2021-03-15
Accepted Time:
2021-03-17 17:10:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1556263 Syros Pharmaceuticals Inc. SYRS Pharmaceutical Preparations (2834) 453772460
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678149 R Eric Olson C/O Syros Pharmaceuticals, Inc.
35 Cambridgepark Drive
Cambridge MA 02140
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-15 3,628 $1.01 3,628 No 4 M Direct
Common Stock Disposition 2021-03-15 3,628 $9.47 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-03-15 3,628 $0.00 3,628 $1.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
90,697 2023-05-22 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.07 to $9.66, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. This option is fully vested.